Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, announced that the US FDA has ruled that the ReCell® Autologous Cell Harvesting Device

This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.

Existing Users Log In
   
Forgot password? Click here to reset
New User Registration
 
 
 
 
 
 
Please indicate that you agree to the Terms of Service *
*Required field